Medical Dissolution of Cholesterol Gallstones Using Oral Aramchol - A Proof of Concept Phase IIa Study
Status:
Terminated
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
This is a one center, Phase IIa, randomized, double blind, placebo controlled study designed
to evaluate the efficacy and safety of two Aramchol doses in subjects 18 to 75 years of age,
with newly formed cholesterol gallstones in their gallbladder following bariatric surgery
confirmed by gallbladder ultrasound ..